Aurinia Pharmaceuticals Newsroom

Retail Investors Who Hold 52% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Gained 5.5%, Institutions Profited as Well

Simply Wall StDec 17 19:14

Aurinia Pharmaceuticals Up Nearly 14%, on Pace for Largest Percent Increase Since January 2023 -- Data Talk

Dow JonesDec 11 02:37

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Zacks Dec 10 20:35

Aurinia Pharmaceuticals(AUPH.US) Director Buys US$10.82 Million in Common Stock

$Aurinia Pharmaceuticals(AUPH.US)$ Director TANG KEVIN purchased 1.2 million shares of common stock on Dec 5, 6, 9, 2024 at an average price of $9.02 for a total value of $10.82 million.Source:

Futu NewsDec 10 05:57

Aurinia Pharmaceuticals Insider Bought Shares Worth $10,822,000, According to a Recent SEC Filing

MT NewswiresDec 10 05:56

Kevin Tang Buys $10.82 Million in Aurinia Pharmaceuticals Shares

InvestingDec 10 05:56

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified

Simply Wall StNov 23 20:31

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 18:44

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 20 09:40 · Ratings

Aurinia Pharmaceuticals Celebrates New Lupus Nephritis Guidelines

TipRanksNov 19 07:42

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 19 06:53

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BreakingsNov 19 06:53

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS in Managing LN at American College of Rheumatology Convergence 2024

BusinesswireNov 15 19:00

Express News | Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of Lupkynis® in Managing Ln at American College of Rheumatology Convergence 2024

BreakingsNov 15 19:00

Aurinia to Participate in Jefferies London Healthcare Conference

BusinesswireNov 14 19:00

RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $9

Futu NewsNov 11 20:31 · Ratings

Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $10.85

Futu NewsNov 11 17:34 · Ratings

Positive Outlook on Aurinia Pharmaceuticals Amid Strong Financial Performance and Strategic Cost Management

TipRanksNov 11 16:35

Leerink Partners Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating

Futu NewsNov 8 15:32 · Ratings

Aurinia Pharmaceuticals Reports Strong Growth and Strategic Restructuring

TipRanksNov 8 12:38